Clinical Trial

Implementing Artificial Intelligence to Prevent Vision Loss From Diabetes

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This pragmatic clinical trial is being conducted to test the effectiveness of AI in improving screening and follow-up eye care compared to usual-care among patients with diabetes across 4 primary care clinics. This is an autonomous AI-based screening to detect diabetic eye disease at primary care visits.
Trial Details
NCT Number NCT07559292
Lead Sponsor University of Wisconsin, Madison
Conditions Vision Disorders, Diabetes
Enrollment 1,700 participants
Start Date 2026-02-15
Primary Completion 2027-02 (estimated)
Study Completion 2027-02 (estimated)
Updated on ClinicalTrials.gov 2026-04-30